This week’s featured articles
Cell & gene therapies (CGT) present an opportunity to fundamentally change the way diseases are treated. These personalized medicines present unique supply-chain and manufacturing challenges that differ from traditional pharmaceutical manufacturing of small molecules and biologics and new digital tools are required to support the scale up/out of CGT.
Life Sciences Knowledge Hub
Stay up to date with industry news
Get the latest digital magazine and up to date news delivered right to your inbox.
Inside this issue
- Cancer Therapies
- Bio International Convention 2022
- Organic Process R&D Conference
- Corporate Responsability